Ligand ID: CP6


Drugbank ID:
DB00205
(Pyrimethamine)



Indication:
For the treatment of toxoplasmosis and acute malaria; For the prevention of malaria in areas non-resistant to pyrimethamine


Get human targets for CP6 in PDB (known and potential targets)

RESULTS FROM SUB-STRUCTURAL SIMILARITY SEARCHES MAPPED TO LIGAND 'CP6' AND SARS-COV-2 / COVID-19 STRUCTURES

1) User may click on the DrReposER ID (the first column) to get information on the binding sites and drug molecule.
2) Click View (the second last column) to view matched residues and superposition in the NGL viewer (upper right part).
3) User may also click on the Dock (the last column) to get script for molecular docking in UCSF Chimera throuh AutoDock Vina.


DrReposER ID / Desc. Hit
PDBID
Hit
Macromolecule
Res.
Matches
View Interface RMSD Seq.
Identity (%)
HETATM Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BLA_A_CP6A302_1
(DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6lxt SPIKE PROTEIN S2
(SARS-CoV-2)
5 / 11
ASP F 979
ASN E 978
SER E 974
ILE E 973
ILE E 980
1.69A17.15
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QGT_A_CP6A609_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6lxt SPIKE PROTEIN S2
(SARS-CoV-2)
5 / 10
ILE D 931
ALA D 930
PHE D 927
SER E1196
ILE E1198
1.56A12.39
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BL9_A_CP6A1240_1
(DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6lxt SPIKE PROTEIN S2
(SARS-CoV-2)
5 / 12
ILE F1198
LEU F1193
PHE F 927
SER D 929
ILE D 931
1.40A17.15
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BL9_A_CP6A1240_1
(DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6lze VIRAL PROTEASE
(SARS-CoV-2)
5 / 12
ASP A 295
PHE A 294
SER A 158
ILE A 152
THR A 292
1.68A18.65
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BL9_A_CP6A1240_1
(DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6m0k VIRAL PROTEASE
(SARS-CoV-2)
5 / 12
ASP A 295
PHE A 294
SER A 158
ILE A 152
THR A 292
1.68A19.18
DMS  A 404 ( 4.8A)
None
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_A_CP6A602_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6m71 NSP12
(SARS-CoV-2)
5 / 12
ALA A 400
THR A 393
ILE A 450
TYR A 674
THR A 402
1.66A14.22
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KM0_A_CP6A201_1
(DIHYDROFOLATE
REDUCTASE)
6m71 NSP12
(SARS-CoV-2)
5 / 10
ALA A 400
THR A 393
ILE A 450
TYR A 674
THR A 402
1.68A10.69
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KM0_B_CP6B201_1
(DIHYDROFOLATE
REDUCTASE)
6m71 NSP12
(SARS-CoV-2)
5 / 12
ALA A 688
ILE A 589
THR A 586
ILE A 696
THR A 687
1.60A10.69
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AOG_A_CP6A704_0
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6m71 NSP12
(SARS-CoV-2)
5 / 10
VAL A 475
ALA A 747
PHE A 745
VAL A 700
TYR A 479
1.61A20.82
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KM0_B_CP6B201_1
(DIHYDROFOLATE
REDUCTASE)
6m71 NSP12
(SARS-CoV-2)
5 / 12
ALA A 400
THR A 393
ILE A 450
TYR A 674
THR A 402
1.65A10.69
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AOG_B_CP6B704_0
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6m71 NSP12
(SARS-CoV-2)
5 / 10
VAL A 475
ALA A 747
PHE A 745
VAL A 700
TYR A 479
1.61A20.82
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BL9_A_CP6A1240_1
(DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6m71 NSP12
(SARS-CoV-2)
5 / 12
ALA A 125
LEU A 240
ASP A 208
SER A 709
THR A 123
1.76A12.71
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_B_CP6B702_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6m71 NSP12
(SARS-CoV-2)
5 / 12
ALA A 400
THR A 393
ILE A 450
TYR A 674
THR A 402
1.65A14.22
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UM5_A_CP6A609_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6vsb SPIKE GLYCOPROTEIN
(SARS-CoV-2)
5 / 10
ILE C 312
VAL C 595
THR C 645
ILE C 666
THR C 315
1.40A19.35
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QG2_B_CP6B709_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6vsb SPIKE GLYCOPROTEIN
(SARS-CoV-2)
5 / 11
ALA C 522
ASN C 542
SER A 982
LEU C 546
THR C 393
1.67A19.09
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_A_CP6A602_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6vsb SPIKE GLYCOPROTEIN
(SARS-CoV-2)
5 / 12
VAL C 615
ALA C 647
THR A 859
SER A 735
THR C 645
1.39A10.59
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1J3J_A_CP6A609_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6vsb SPIKE GLYCOPROTEIN
(SARS-CoV-2)
5 / 10
ILE B 931
PHE B 927
ILE B 882
ILE B 805
THR B 723
1.78A11.79
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BLA_A_CP6A302_1
(DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6vsb SPIKE GLYCOPROTEIN
(SARS-CoV-2)
5 / 11
ILE B 931
PHE B 927
ILE B 882
ILE B 805
THR B 723
1.73A11.05
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UM5_A_CP6A609_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6vww URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)
5 / 10
ILE B 307
VAL B 237
PHE B 342
ILE B 328
ILE B 306
1.48A19.94
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BL9_A_CP6A1240_1
(DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6vww URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)
5 / 12
LEU A 120
SER A  98
ILE A  97
ILE B 108
THR B 115
1.18A22.34
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KM0_A_CP6A201_1
(DIHYDROFOLATE
REDUCTASE)
6vxx SPIKE GLYCOPROTEIN
(SARS-CoV-2)
5 / 10
ILE B 101
ALA B 264
PHE B  92
LEU B  84
THR B  95
1.53A8.82
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KM0_B_CP6B201_1
(DIHYDROFOLATE
REDUCTASE)
6vxx SPIKE GLYCOPROTEIN
(SARS-CoV-2)
5 / 12
ILE B 101
ALA B 264
PHE B  92
LEU B  84
THR B  95
1.51A8.82
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QG2_B_CP6B709_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6vxx SPIKE GLYCOPROTEIN
(SARS-CoV-2)
5 / 11
ALA C 522
PHE C 392
SER A 982
LEU C 517
THR C 523
1.61A18.94
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_A_CP6A602_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6vxx SPIKE GLYCOPROTEIN
(SARS-CoV-2)
5 / 12
ILE C 805
PHE C1062
THR C 881
LEU C 877
THR C 724
1.34A10.68
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UM5_A_CP6A609_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6vxx SPIKE GLYCOPROTEIN
(SARS-CoV-2)
5 / 10
ILE C 312
VAL C 595
THR C 645
ILE C 666
THR C 315
1.33A19.10
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UM5_A_CP6A609_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6vyb SPIKE GLYCOPROTEIN
(SARS-CoV-2)
5 / 10
ILE C 312
VAL C 595
THR C 645
ILE C 666
THR C 315
1.34A19.10
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KM0_A_CP6A201_1
(DIHYDROFOLATE
REDUCTASE)
6vyb SPIKE GLYCOPROTEIN
(SARS-CoV-2)
5 / 10
ILE B 101
ALA B 264
PHE B  92
LEU B  84
THR B  95
1.52A8.82
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_A_CP6A602_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6vyb SPIKE GLYCOPROTEIN
(SARS-CoV-2)
5 / 12
VAL A 615
ALA A 647
THR B 859
SER B 735
THR A 645
1.30A10.68
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QG2_B_CP6B709_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6vyb SPIKE GLYCOPROTEIN
(SARS-CoV-2)
5 / 11
ALA A 522
PHE A 392
SER B 982
LEU A 517
THR A 523
1.49A18.94
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KM0_B_CP6B201_1
(DIHYDROFOLATE
REDUCTASE)
6vyb SPIKE GLYCOPROTEIN
(SARS-CoV-2)
5 / 12
ILE B 101
ALA B 264
PHE B  92
LEU B  84
THR B  95
1.49A8.82
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QGT_A_CP6A609_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6w4h SARS-COV-2 NSP16
(SARS-CoV-2)
5 / 10
ILE A6925
ALA A6960
PHE A6954
ILE A7088
ILE A6866
1.45A18.56
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BLA_A_CP6A302_1
(DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6w4h NSP16
(SARS-CoV-2)
5 / 11
ILE A6925
ALA A6960
PHE A6954
ILE A7088
ILE A6866
1.39A22.87
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BL9_A_CP6A1240_1
(DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6w4h NSP16
(SARS-CoV-2)
5 / 12
ILE A6925
ALA A6960
PHE A6954
ILE A7088
ILE A6866
1.45A22.87
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KM0_A_CP6A201_1
(DIHYDROFOLATE
REDUCTASE)
6w4h NSP16
(SARS-CoV-2)
5 / 10
ILE A6866
ALA A6905
ASP A6895
LEU A6848
THR A6908
1.74A20.07
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_A_CP6A602_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6w4h NSP10
(SARS-CoV-2)
5 / 12
VAL B4350
MET B4375
THR B4354
ILE B4352
THR B4309
1.43A17.15
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_A_CP6A602_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6w61 NSP10
(SARS-CoV-2)
5 / 12
VAL B4350
MET B4375
THR B4354
ILE B4352
THR B4309
1.43A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_B_CP6B702_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6w61 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
5 / 12
VAL A6992
ALA A6808
SER A6800
ILE A7035
THR A6989
1.80A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UM5_B_CP6B709_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6w61 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
5 / 10
ILE A6951
PHE A6868
THR A6918
SER A7089
ILE A7088
1.60A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_A_CP6A602_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6w61 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
5 / 12
VAL A6807
ALA A6990
LEU A6825
ILE A7035
THR A6989
1.70A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BLA_A_CP6A302_1
(DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6w61 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
5 / 11
ILE A6925
ALA A6960
PHE A6954
ILE A7088
ILE A6866
1.38A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UM5_A_CP6A609_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6w61 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
5 / 10
ILE A6951
PHE A6868
THR A6918
SER A7089
ILE A7088
1.64A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QGT_A_CP6A609_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6w61 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
5 / 10
ILE A6925
ALA A6960
PHE A6954
ILE A7088
ILE A6866
1.44A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UM5_B_CP6B709_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6w61 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
5 / 10
ILE A6951
PHE A6868
THR A6918
SER A7089
THR A6949
1.76A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BL9_A_CP6A1240_1
(DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6w61 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
5 / 12
ILE A7005
ALA A6990
PHE A6991
SER A6999
THR A6989
1.78A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KM0_A_CP6A201_1
(DIHYDROFOLATE
REDUCTASE)
6w61 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
5 / 10
ILE A6866
ALA A6905
ASP A6895
LEU A6848
THR A6908
1.75A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KM0_B_CP6B201_1
(DIHYDROFOLATE
REDUCTASE)
6w61 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
5 / 12
ILE A6866
ALA A6905
ASP A6895
LEU A6848
THR A6908
1.72A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QGT_B_CP6B609_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6w61 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
5 / 10
ILE A6925
ALA A6960
PHE A6954
ILE A7088
ILE A6866
1.35A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1J3J_A_CP6A609_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6w61 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
5 / 10
ILE A6925
ALA A6960
PHE A6954
ILE A7088
ILE A6866
1.46A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BLA_A_CP6A302_1
(DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6w61 2'-O-METHYLTRANSFERA
SE
NSP10
(SARS-CoV-2)
5 / 11
ALA A6881
ASP A6904
ASN B4293
ILE B4291
THR A6880
1.74A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_B_CP6B702_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6w61 NSP10
(SARS-CoV-2)
5 / 12
VAL B4350
MET B4375
THR B4354
ILE B4352
THR B4309
1.43A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_B_CP6B702_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6w61 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
5 / 12
VAL A6807
ALA A6990
LEU A6825
ILE A7035
THR A6989
1.69A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QGT_A_CP6A609_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6w61 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
5 / 10
ALA A6990
PHE A7003
SER A7000
SER A6999
THR A6989
1.76A
None
None
KCX  A6935 ( 3.7A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KM0_B_CP6B201_1
(DIHYDROFOLATE
REDUCTASE)
6w61 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
5 / 12
ILE A6866
ALA A6905
LEU A6848
ILE A6926
THR A6908
1.80A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QGT_B_CP6B609_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6w61 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
5 / 10
ILE A7079
ALA A7056
ILE A7065
ILE A7080
THR A7055
1.49A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BL9_A_CP6A1240_1
(DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6w61 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
5 / 12
ILE A6925
ALA A6960
PHE A6954
ILE A7088
ILE A6866
1.44A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KM0_B_CP6B201_1
(DIHYDROFOLATE
REDUCTASE)
6w63 3C-LIKE PROTEINASE
(SARS-CoV-2)
5 / 12
ASP A 295
GLN A 127
PHE A   8
ILE A 152
TYR A 154
1.71A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BL9_A_CP6A1240_1
(DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6w63 3C-LIKE PROTEINASE
(SARS-CoV-2)
5 / 12
ASP A 295
PHE A   8
SER A 158
ILE A 152
TYR A 154
1.74A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_A_CP6A602_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6w6y NSP3
(SARS-CoV-2)
5 / 12
ALA A 124
ILE A  23
LEU A 160
ILE A  18
TYR A   9
1.73A
None
AMP  A 201 ( 4.0A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_B_CP6B702_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6w6y NSP3
(SARS-CoV-2)
5 / 12
ALA B 124
ILE B  23
LEU B 160
ILE B  18
TYR B   9
1.74A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_B_CP6B702_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6w6y NSP3
(SARS-CoV-2)
5 / 12
ALA A 124
ILE A  23
LEU A 160
ILE A  18
TYR A   9
1.73A
None
AMP  A 201 ( 4.0A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_A_CP6A602_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6w6y NSP3
(SARS-CoV-2)
5 / 12
ALA B 124
ILE B  23
LEU B 160
ILE B  18
TYR B   9
1.74A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_B_CP6B702_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6w75 NSP16
(SARS-CoV-2)
5 / 12
VAL A6807
ALA A6990
LEU A6825
ILE A7035
THR A6989
1.68A18.03
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_B_CP6B702_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6w75 NSP16
(SARS-CoV-2)
5 / 12
VAL C6807
ALA C6990
LEU C6825
ILE C7035
THR C6989
1.68A18.03
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_A_CP6A602_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6w75 NSP10
(SARS-CoV-2)
5 / 12
VAL B4350
MET B4375
THR B4354
ILE B4352
THR B4309
1.47A17.15
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_A_CP6A602_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6w75 NSP10
(SARS-CoV-2)
5 / 12
VAL D4350
MET D4375
THR D4354
ILE D4352
THR D4309
1.46A17.15
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BLA_A_CP6A302_1
(DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6w75 NSP16
(SARS-CoV-2)
5 / 11
ILE A6925
ALA A6960
PHE A6954
ILE A7088
ILE A6866
1.42A21.37
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KM0_B_CP6B201_1
(DIHYDROFOLATE
REDUCTASE)
6w75 NSP16
(SARS-CoV-2)
5 / 12
ILE A6866
ALA A6905
ASP A6895
LEU A6848
THR A6908
1.73A20.60
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QGT_B_CP6B609_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6w75 NSP16
(SARS-CoV-2)
5 / 10
ILE C6925
ALA C6960
PHE C6954
ILE C7088
ILE C6866
1.35A13.46
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1J3J_A_CP6A609_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6w75 NSP16
(SARS-CoV-2)
5 / 10
ILE A6925
ALA A6960
PHE A6954
ILE A7088
ILE A6866
1.47A18.21
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BL9_A_CP6A1240_1
(DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6w75 NSP16
(SARS-CoV-2)
5 / 12
ILE A6925
ALA A6960
PHE A6954
ILE A7088
ILE A6866
1.45A21.37
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_A_CP6A602_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6w75 NSP16
(SARS-CoV-2)
5 / 12
VAL C6807
ALA C6990
LEU C6825
ILE C7035
THR C6989
1.70A18.03
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BLA_A_CP6A302_1
(DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6w75 NSP10
NSP16
(SARS-CoV-2)
5 / 11
ALA A6881
ASP A6904
ASN B4293
ILE B4291
THR A6880
1.70A21.37
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KM0_A_CP6A201_1
(DIHYDROFOLATE
REDUCTASE)
6w75 NSP16
(SARS-CoV-2)
5 / 10
ILE C6866
ALA C6905
ASP C6895
LEU C6848
THR C6908
1.76A20.60
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KM0_A_CP6A201_1
(DIHYDROFOLATE
REDUCTASE)
6w75 NSP16
(SARS-CoV-2)
5 / 10
ILE A6866
ALA A6905
ASP A6895
LEU A6848
THR A6908
1.76A20.60
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KM0_B_CP6B201_1
(DIHYDROFOLATE
REDUCTASE)
6w75 NSP16
(SARS-CoV-2)
5 / 12
ILE C6866
ALA C6905
ASP C6895
LEU C6848
THR C6908
1.73A20.60
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QGT_B_CP6B609_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6w75 NSP16
(SARS-CoV-2)
5 / 10
ILE A6925
ALA A6960
PHE A6954
ILE A7088
ILE A6866
1.36A13.46
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_A_CP6A602_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6w75 NSP16
(SARS-CoV-2)
5 / 12
VAL A6807
ALA A6990
LEU A6825
ILE A7035
THR A6989
1.69A18.03
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BLA_A_CP6A302_1
(DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6w75 NSP16
(SARS-CoV-2)
5 / 11
ILE C6925
ALA C6960
PHE C6954
ILE C7088
ILE C6866
1.41A21.37
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QGT_A_CP6A609_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6w75 NSP16
(SARS-CoV-2)
5 / 10
ALA A6990
PHE A7003
SER A7000
SER A6999
THR A6989
1.76A13.46
None
None
FMT  A7105 ( 2.6A)
FMT  A7104 ( 2.9A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_B_CP6B702_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6w75 NSP16
(SARS-CoV-2)
5 / 12
VAL C6992
ALA C6808
SER C6800
ILE C7035
THR C6989
1.77A18.03
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QGT_B_CP6B609_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6w75 NSP16
(SARS-CoV-2)
5 / 10
ILE A7079
ALA A7056
ILE A7065
ILE A7080
THR A7055
1.53A13.46
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BL9_A_CP6A1240_1
(DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6w75 NSP16
(SARS-CoV-2)
5 / 12
ILE C6925
ALA C6960
PHE C6954
ILE C7088
ILE C6866
1.45A21.37
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QGT_A_CP6A609_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6w75 NSP16
(SARS-CoV-2)
5 / 10
ILE A6925
ALA A6960
PHE A6954
ILE A7088
ILE A6866
1.45A13.46
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QGT_A_CP6A609_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6w75 NSP16
(SARS-CoV-2)
5 / 10
ILE C6925
ALA C6960
PHE C6954
ILE C7088
ILE C6866
1.45A13.46
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BLA_A_CP6A302_1
(DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6w75 NSP10
NSP16
(SARS-CoV-2)
5 / 11
ALA C6881
ASP C6904
ASN D4293
ILE D4291
THR C6880
1.69A21.37
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_A_CP6A602_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6w75 NSP16
(SARS-CoV-2)
5 / 12
VAL C6992
ALA C6808
SER C6800
ILE C7035
THR C6989
1.78A18.03
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_B_CP6B702_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6w75 NSP10
(SARS-CoV-2)
5 / 12
VAL D4350
MET D4375
THR D4354
ILE D4352
THR D4309
1.46A17.15
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1J3J_A_CP6A609_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6w75 NSP16
(SARS-CoV-2)
5 / 10
ILE C6925
ALA C6960
PHE C6954
ILE C7088
ILE C6866
1.46A18.21
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QGT_B_CP6B609_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6w75 NSP16
(SARS-CoV-2)
5 / 10
ILE C7079
ALA C7056
ILE C7065
ILE C7080
THR C7055
1.62A13.46
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_B_CP6B702_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6w75 NSP10
(SARS-CoV-2)
5 / 12
VAL B4350
MET B4375
THR B4354
ILE B4352
THR B4309
1.47A17.15
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BL9_A_CP6A1240_1
(DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6w75 NSP16
(SARS-CoV-2)
5 / 12
ILE C7005
ALA C6990
PHE C6991
SER C6999
THR C6989
1.78A21.37
None
None
None
FMT  C7108 ( 2.7A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QGT_A_CP6A609_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6w75 NSP16
(SARS-CoV-2)
5 / 10
ALA C6990
PHE C7003
SER C7000
SER C6999
THR C6989
1.76A13.46
None
None
FMT  C7110 ( 2.8A)
FMT  C7108 ( 2.7A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BL9_A_CP6A1240_1
(DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6w75 NSP16
(SARS-CoV-2)
5 / 12
ILE A7005
ALA A6990
PHE A6991
SER A6999
THR A6989
1.79A21.37
None
None
None
FMT  A7104 ( 2.9A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QG2_B_CP6B709_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6w9c PAPAIN-LIKE
PROTEINASE
(SARS-CoV-2)
5 / 11
ILE A 151
ALA A  86
ASN A 156
SER A  78
THR A  90
1.70A19.77
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KM0_A_CP6A201_1
(DIHYDROFOLATE
REDUCTASE)
6w9c PAPAIN-LIKE
PROTEINASE
(SARS-CoV-2)
5 / 10
ALA C 135
THR C  10
LEU C  16
ILE C  14
TYR C  72
1.75A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QG2_B_CP6B709_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6w9c PAPAIN-LIKE
PROTEINASE
(SARS-CoV-2)
5 / 11
ILE C 123
PHE C 241
SER C 180
LEU C 125
THR C 259
1.78A19.77
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QG2_B_CP6B709_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6w9c PAPAIN-LIKE
PROTEINASE
(SARS-CoV-2)
5 / 11
ILE C 151
ALA C 149
PHE C 147
LEU C 132
TYR C 154
1.75A19.77
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QG2_B_CP6B709_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6w9c PAPAIN-LIKE
PROTEINASE
(SARS-CoV-2)
5 / 11
ILE A 151
ALA A 149
PHE A 147
LEU A 132
TYR A 154
1.76A19.77
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KM0_B_CP6B201_1
(DIHYDROFOLATE
REDUCTASE)
6w9c PAPAIN-LIKE
PROTEINASE
(SARS-CoV-2)
5 / 12
ILE A 151
ALA A 149
PHE A 147
TYR A 154
THR A  90
1.76A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QG2_A_CP6A609_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6w9c PAPAIN-LIKE
PROTEINASE
(SARS-CoV-2)
5 / 10
ILE A 151
ALA A  86
ASN A 156
SER A  78
THR A  90
1.66A19.77
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KM0_A_CP6A201_1
(DIHYDROFOLATE
REDUCTASE)
6w9c PAPAIN-LIKE
PROTEINASE
(SARS-CoV-2)
5 / 10
ILE A 151
ALA A 149
PHE A 147
TYR A 154
THR A  90
1.78A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QG2_B_CP6B709_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6w9c PAPAIN-LIKE
PROTEINASE
(SARS-CoV-2)
5 / 11
ILE B 123
PHE B 241
SER B 180
LEU B 125
THR B 259
1.78A19.77
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KM0_B_CP6B201_1
(DIHYDROFOLATE
REDUCTASE)
6w9c PAPAIN-LIKE
PROTEINASE
(SARS-CoV-2)
5 / 12
ALA C 116
ILE C 151
THR C  90
ILE C 104
THR C 119
1.78A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1J3J_A_CP6A609_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6w9c PAPAIN-LIKE
PROTEINASE
(SARS-CoV-2)
5 / 10
ILE A 151
ALA A  86
ASN A 156
SER A  78
THR A  90
1.65A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BL9_A_CP6A1240_1
(DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6w9c PAPAIN-LIKE
PROTEINASE
(SARS-CoV-2)
5 / 12
ILE C 300
PHE C 258
SER C 293
SER C 294
ILE C 276
1.70A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KM0_B_CP6B201_1
(DIHYDROFOLATE
REDUCTASE)
6w9c PAPAIN-LIKE
PROTEINASE
(SARS-CoV-2)
5 / 12
ALA C 135
THR C  10
LEU C  16
ILE C  14
TYR C  72
1.74A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_B_CP6B702_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wcf NSP3
(SARS-CoV-2)
5 / 12
ALA A 124
ILE A  23
LEU A 160
ILE A  18
TYR A   9
1.75A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_A_CP6A602_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wcf NSP3
(SARS-CoV-2)
5 / 12
ALA A 124
ILE A  23
LEU A 160
ILE A  18
TYR A   9
1.76A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_A_CP6A602_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wen NSP3
(SARS-CoV-2)
5 / 12
ALA A 124
ILE A  23
LEU A 160
ILE A  18
TYR A   9
1.73A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_B_CP6B702_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wen NSP3
(SARS-CoV-2)
5 / 12
ALA A 124
ILE A  23
LEU A 160
ILE A  18
TYR A   9
1.73A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_B_CP6B702_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wey NSP3
(SARS-CoV-2)
5 / 12
ALA A 328
ILE A 227
LEU A 364
ILE A 222
TYR A 213
1.75A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_A_CP6A602_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wey NSP3
(SARS-CoV-2)
5 / 12
ALA A 328
ILE A 227
LEU A 364
ILE A 222
TYR A 213
1.75A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BL9_A_CP6A1240_1
(DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wiq NSP7
NSP8
(SARS-CoV-2)
5 / 12
ALA B 152
LEU B 122
SER A  57
ILE B 106
TYR B 149
1.80A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QG2_B_CP6B709_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wiq NSP7
NSP8
(SARS-CoV-2)
5 / 11
ILE B 185
ALA B 188
ASN B 118
SER A  57
LEU B 117
1.62A10.80
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KM0_B_CP6B201_1
(DIHYDROFOLATE
REDUCTASE)
6wji NUCLEOCAPSID PROTEIN
(SARS-CoV-2)
5 / 12
ILE A 357
ALA A 359
ILE A 292
PHE A 286
ILE B 320
1.80A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KM0_B_CP6B201_1
(DIHYDROFOLATE
REDUCTASE)
6wji NUCLEOCAPSID PROTEIN
(SARS-CoV-2)
5 / 12
ILE C 357
ALA C 359
ILE C 292
PHE C 286
ILE D 320
1.80A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KM0_B_CP6B201_1
(DIHYDROFOLATE
REDUCTASE)
6wji NUCLEOCAPSID PROTEIN
(SARS-CoV-2)
5 / 12
ILE D 357
ALA D 359
ILE D 292
PHE D 286
ILE C 320
1.76A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KM0_B_CP6B201_1
(DIHYDROFOLATE
REDUCTASE)
6wji NUCLEOCAPSID PROTEIN
(SARS-CoV-2)
5 / 12
ILE F 357
ALA F 359
ILE F 292
PHE F 286
ILE E 320
1.80A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KM0_B_CP6B201_1
(DIHYDROFOLATE
REDUCTASE)
6wji NUCLEOCAPSID PROTEIN
(SARS-CoV-2)
5 / 12
ILE E 357
ALA E 359
ILE E 292
PHE E 286
ILE F 320
1.78A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UM5_B_CP6B709_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wji NUCLEOCAPSID PROTEIN
(SARS-CoV-2)
5 / 10
VAL B 270
PHE A 315
ILE B 357
ILE B 304
TYR B 298
1.78A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_A_CP6A602_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wjt NSP10
(SARS-CoV-2)
5 / 12
VAL D4350
MET D4375
THR D4354
ILE D4352
THR D4309
1.47A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BL9_A_CP6A1240_1
(DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
5 / 12
ILE C7005
ALA C6990
PHE C6991
SER C6999
THR C6989
1.80A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_A_CP6A602_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
5 / 12
VAL A6807
ALA A6990
LEU A6825
ILE A7035
THR A6989
1.69A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QGT_B_CP6B609_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
5 / 10
ILE A7079
ALA A7056
ILE A7065
ILE A7080
THR A7055
1.60A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KM0_B_CP6B201_1
(DIHYDROFOLATE
REDUCTASE)
6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
5 / 12
ILE A6866
ALA A6905
ASP A6895
LEU A6848
THR A6908
1.72A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_A_CP6A602_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wjt NSP10
(SARS-CoV-2)
5 / 12
VAL B4350
MET B4375
THR B4354
ILE B4352
THR B4309
1.46A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BLA_A_CP6A302_1
(DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
5 / 11
ILE A6925
ALA A6960
PHE A6954
ILE A7088
ILE A6866
1.41A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_B_CP6B702_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wjt NSP10
(SARS-CoV-2)
5 / 12
VAL D4350
MET D4375
THR D4354
ILE D4352
THR D4309
1.46A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QGT_B_CP6B609_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
5 / 10
ILE A6925
ALA A6960
PHE A6954
ILE A7088
ILE A6866
1.36A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QGT_B_CP6B609_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
5 / 10
ILE C6925
ALA C6960
PHE C6954
ILE C7088
ILE C6866
1.35A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_B_CP6B702_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
5 / 12
VAL C6807
ALA C6990
LEU C6825
ILE C7035
THR C6989
1.69A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_B_CP6B702_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
5 / 12
VAL A6807
ALA A6990
LEU A6825
ILE A7035
THR A6989
1.67A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_A_CP6A602_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
5 / 12
VAL C6807
ALA C6990
LEU C6825
ILE C7035
THR C6989
1.70A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QGT_A_CP6A609_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
5 / 10
ILE A6925
ALA A6960
PHE A6954
ILE A7088
ILE A6866
1.45A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1J3J_A_CP6A609_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
5 / 10
ILE C6925
ALA C6960
PHE C6954
ILE C7088
ILE C6866
1.47A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UM5_B_CP6B709_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
5 / 10
ILE A6951
PHE A6868
THR A6918
SER A7089
THR A6949
1.76A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QGT_B_CP6B609_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
5 / 10
ALA C6808
SER C6799
SER C6800
ILE C7035
THR C6989
1.69A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QGT_A_CP6A609_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
5 / 10
ALA A6990
PHE A7003
SER A7000
SER A6999
THR A6989
1.76A
None
None
FMT  A7104 ( 2.9A)
FMT  A7104 (-3.1A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BL9_A_CP6A1240_1
(DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
5 / 12
ILE C6925
ALA C6960
PHE C6954
ILE C7088
ILE C6866
1.46A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BLA_A_CP6A302_1
(DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
5 / 11
ILE C6925
ALA C6960
PHE C6954
ILE C7088
ILE C6866
1.41A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QGT_A_CP6A609_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
5 / 10
ILE C6925
ALA C6960
PHE C6954
ILE C7088
ILE C6866
1.45A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1J3J_A_CP6A609_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
5 / 10
ILE A6925
ALA A6960
PHE A6954
ILE A7088
ILE A6866
1.47A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QGT_A_CP6A609_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
5 / 10
ILE A7079
ALA A7056
ILE A7065
ILE A7080
THR A7055
1.75A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BL9_A_CP6A1240_1
(DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
5 / 12
ILE A7079
ALA A7056
ILE A7065
ILE A7080
THR A7055
1.77A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BL9_A_CP6A1240_1
(DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
5 / 12
ILE A6925
ALA A6960
PHE A6954
ILE A7088
ILE A6866
1.45A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QGT_A_CP6A609_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
5 / 10
ALA C6990
PHE C7003
SER C7000
SER C6999
THR C6989
1.75A
None
None
FMT  C7104 ( 3.7A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UM5_B_CP6B709_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
5 / 10
ILE A6951
PHE A6868
THR A6918
SER A7089
ILE A7088
1.58A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_B_CP6B702_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wjt NSP10
(SARS-CoV-2)
5 / 12
VAL B4350
MET B4375
THR B4354
ILE B4352
THR B4309
1.46A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KM0_B_CP6B201_1
(DIHYDROFOLATE
REDUCTASE)
6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
5 / 12
ILE C6866
ALA C6905
ASP C6895
LEU C6848
THR C6908
1.73A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BLA_A_CP6A302_1
(DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wjt 2'-O-METHYLTRANSFERA
SE
NSP10
(SARS-CoV-2)
5 / 11
ALA A6881
ASP A6904
ASN B4293
ILE B4291
THR A6880
1.71A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BL9_A_CP6A1240_1
(DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
5 / 12
ILE A7005
ALA A6990
PHE A6991
SER A6999
THR A6989
1.77A
None
None
None
FMT  A7104 (-3.1A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BLA_A_CP6A302_1
(DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wjt 2'-O-METHYLTRANSFERA
SE
NSP10
(SARS-CoV-2)
5 / 11
ALA C6881
ASP C6904
ASN D4293
ILE D4291
THR C6880
1.70A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UM5_A_CP6A609_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
5 / 10
ILE A6951
PHE A6868
THR A6918
SER A7089
ILE A7088
1.62A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BLA_A_CP6A302_1
(DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
5 / 11
ILE A7079
ALA A7056
ILE A7065
ILE A7080
THR A7055
1.69A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KM0_A_CP6A201_1
(DIHYDROFOLATE
REDUCTASE)
6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
5 / 10
ILE C6866
ALA C6905
ASP C6895
LEU C6848
THR C6908
1.76A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KM0_A_CP6A201_1
(DIHYDROFOLATE
REDUCTASE)
6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
5 / 10
ILE A6866
ALA A6905
ASP A6895
LEU A6848
THR A6908
1.75A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QGT_B_CP6B609_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
5 / 10
ILE C7079
ALA C7056
ILE C7065
ILE C7080
THR C7055
1.59A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1J3J_A_CP6A609_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
5 / 10
ILE A7079
ALA A7056
ILE A7065
ILE A7080
THR A7055
1.74A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UM5_B_CP6B709_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wkq NSP16
(SARS-CoV-2)
5 / 10
ILE A6951
PHE A6868
THR A6918
SER A7089
THR A6949
1.79A
None
None
FMT  A7108 ( 4.8A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QGT_A_CP6A609_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wkq NSP16
(SARS-CoV-2)
5 / 10
ILE A6925
ALA A6960
PHE A6954
ILE A7088
ILE A6866
1.45A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KM0_A_CP6A201_1
(DIHYDROFOLATE
REDUCTASE)
6wkq NSP16
(SARS-CoV-2)
5 / 10
ILE C6866
ALA C6905
ASP C6895
LEU C6848
THR C6908
1.74A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BLA_A_CP6A302_1
(DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wkq NSP10
NSP16
(SARS-CoV-2)
5 / 11
ALA C6881
ASP C6904
ASN D4293
ILE D4291
THR C6880
1.70A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QGT_B_CP6B609_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wkq NSP16
(SARS-CoV-2)
5 / 10
ILE C6925
ALA C6960
PHE C6954
ILE C7088
ILE C6866
1.36A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QGT_A_CP6A609_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wkq NSP16
(SARS-CoV-2)
5 / 10
ALA C6990
PHE C7003
SER C7000
SER C6999
THR C6989
1.76A
None
None
FMT  C7110 ( 3.0A)
FMT  C7110 ( 3.1A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BLA_A_CP6A302_1
(DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wkq NSP10
NSP16
(SARS-CoV-2)
5 / 11
ALA A6881
ASP A6904
ASN B4293
ILE B4291
THR A6880
1.71A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_B_CP6B702_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wkq NSP10
(SARS-CoV-2)
5 / 12
VAL D4350
MET D4375
THR D4354
ILE D4352
THR D4309
1.46A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BLA_A_CP6A302_1
(DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wkq NSP16
(SARS-CoV-2)
5 / 11
ILE C6925
ALA C6960
PHE C6954
ILE C7088
ILE C6866
1.43A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1J3J_A_CP6A609_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wkq NSP16
(SARS-CoV-2)
5 / 10
ILE A6925
ALA A6960
PHE A6954
ILE A7088
ILE A6866
1.47A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_B_CP6B702_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wkq NSP10
(SARS-CoV-2)
5 / 12
VAL B4350
MET B4375
THR B4354
ILE B4352
THR B4309
1.46A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BL9_A_CP6A1240_1
(DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wkq NSP16
(SARS-CoV-2)
5 / 12
ILE A6925
ALA A6960
PHE A6954
ILE A7088
ILE A6866
1.45A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BL9_A_CP6A1240_1
(DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wkq NSP16
(SARS-CoV-2)
5 / 12
ILE C7005
ALA C6990
PHE C6991
SER C6999
THR C6989
1.79A
None
None
None
FMT  C7110 ( 3.1A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UM5_B_CP6B709_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wkq NSP16
(SARS-CoV-2)
5 / 10
ILE A6951
PHE A6868
THR A6918
SER A7089
ILE A7088
1.61A
None
None
FMT  A7108 ( 4.8A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KM0_B_CP6B201_1
(DIHYDROFOLATE
REDUCTASE)
6wkq NSP16
(SARS-CoV-2)
5 / 12
ILE C6866
ALA C6905
ASP C6895
LEU C6848
THR C6908
1.72A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_A_CP6A602_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wkq NSP10
(SARS-CoV-2)
5 / 12
VAL B4350
MET B4375
THR B4354
ILE B4352
THR B4309
1.46A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QGT_A_CP6A609_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wkq NSP16
(SARS-CoV-2)
5 / 10
ILE C6925
ALA C6960
PHE C6954
ILE C7088
ILE C6866
1.46A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QGT_B_CP6B609_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wkq NSP16
(SARS-CoV-2)
5 / 10
ILE C7079
ALA C7056
ILE C7065
ILE C7080
THR C7055
1.60A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KM0_B_CP6B201_1
(DIHYDROFOLATE
REDUCTASE)
6wkq NSP16
(SARS-CoV-2)
5 / 12
ILE A6866
ALA A6905
ASP A6895
LEU A6848
THR A6908
1.72A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_B_CP6B702_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wkq NSP16
(SARS-CoV-2)
5 / 12
VAL C6807
ALA C6990
LEU C6825
ILE C7035
THR C6989
1.69A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QGT_B_CP6B609_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wkq NSP16
(SARS-CoV-2)
5 / 10
ILE A6925
ALA A6960
PHE A6954
ILE A7088
ILE A6866
1.35A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_B_CP6B702_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wkq NSP16
(SARS-CoV-2)
5 / 12
VAL A6807
ALA A6990
LEU A6825
ILE A7035
THR A6989
1.68A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_A_CP6A602_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wkq NSP16
(SARS-CoV-2)
5 / 12
VAL C6807
ALA C6990
LEU C6825
ILE C7035
THR C6989
1.70A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QGT_B_CP6B609_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wkq NSP16
(SARS-CoV-2)
5 / 10
ILE A7079
ALA A7056
ILE A7065
ILE A7080
THR A7055
1.55A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QGT_A_CP6A609_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wkq NSP16
(SARS-CoV-2)
5 / 10
ALA A6990
PHE A7003
SER A7000
SER A6999
THR A6989
1.76A
None
None
FMT  A7106 ( 2.8A)
FMT  A7106 ( 3.2A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KM0_A_CP6A201_1
(DIHYDROFOLATE
REDUCTASE)
6wkq NSP16
(SARS-CoV-2)
5 / 10
ILE A6866
ALA A6905
ASP A6895
LEU A6848
THR A6908
1.74A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BL9_A_CP6A1240_1
(DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wkq NSP16
(SARS-CoV-2)
5 / 12
ILE C6925
ALA C6960
PHE C6954
ILE C7088
ILE C6866
1.47A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_A_CP6A602_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wkq NSP16
(SARS-CoV-2)
5 / 12
VAL A6807
ALA A6990
LEU A6825
ILE A7035
THR A6989
1.70A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1J3J_A_CP6A609_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wkq NSP16
(SARS-CoV-2)
5 / 10
ILE C6925
ALA C6960
PHE C6954
ILE C7088
ILE C6866
1.48A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_A_CP6A602_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wkq NSP10
(SARS-CoV-2)
5 / 12
VAL D4350
MET D4375
THR D4354
ILE D4352
THR D4309
1.46A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BLA_A_CP6A302_1
(DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wkq NSP16
(SARS-CoV-2)
5 / 11
ILE A6925
ALA A6960
PHE A6954
ILE A7088
ILE A6866
1.42A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BLA_A_CP6A302_1
(DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wlc URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)
5 / 11
ILE A 307
MET A 331
PHE A 342
ILE A 328
ILE A 306
1.78A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UM5_A_CP6A609_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wlc URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)
5 / 10
ILE A 307
VAL A 237
PHE A 342
ILE A 328
ILE A 306
1.51A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QG2_B_CP6B709_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wlc URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)
5 / 11
ILE A 307
ALA A 232
PHE A 233
LEU A 228
THR A 341
1.73A18.96
None
None
None
None
U5P  A 401 ( 4.7A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UM5_A_CP6A609_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wlc URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)
5 / 10
ILE B 307
VAL B 237
PHE B 342
ILE B 328
ILE B 306
1.52A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_A_CP6A602_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wlc URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)
5 / 12
ILE A 212
PHE A 204
SER A 208
LEU A 299
ILE A 253
1.76A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BL9_A_CP6A1240_1
(DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wlc URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)
5 / 12
ILE B 323
LEU B 300
ASP B 302
ILE B 236
ILE B 296
1.71A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_B_CP6B702_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wlc URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)
5 / 12
ILE A 212
PHE A 204
SER A 208
LEU A 299
ILE A 253
1.77A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BL9_A_CP6A1240_1
(DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wlc URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)
5 / 12
LEU A 120
SER A  98
ILE A  97
ILE B 108
THR B 115
1.36A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QG2_B_CP6B709_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wlc URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)
5 / 11
ILE B 307
ALA B 232
PHE B 233
LEU B 228
THR B 341
1.71A18.96
None
None
None
None
U5P  B 401 ( 4.8A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UM5_A_CP6A609_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wlc URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)
5 / 10
ILE A 307
VAL A 237
PHE A 342
ILE A 323
ILE A 306
1.62A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_A_CP6A602_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wlc URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)
5 / 12
ILE B 212
PHE B 204
SER B 208
LEU B 299
ILE B 253
1.76A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UM5_A_CP6A609_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wlc URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)
5 / 10
ILE B 307
VAL B 237
PHE B 342
ILE B 323
ILE B 306
1.65A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BL9_A_CP6A1240_1
(DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wlc URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)
5 / 12
LEU B 120
SER B  98
ILE B  97
ILE A 108
THR A 115
1.53A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_B_CP6B702_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wlc URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)
5 / 12
ILE B 212
PHE B 204
SER B 208
LEU B 299
ILE B 253
1.76A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BL9_A_CP6A1240_1
(DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wlc URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)
5 / 12
ILE A 323
LEU A 300
ASP A 302
ILE A 236
ILE A 296
1.71A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BLA_A_CP6A302_1
(DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wlc URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)
5 / 11
ILE B 307
MET B 331
PHE B 342
ILE B 328
ILE B 306
1.76A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_B_CP6B702_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)
5 / 12
ALA D 124
ILE D  23
LEU D 160
ILE D  18
TYR D   9
1.74A
None
APR  D 201 (-3.8A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_A_CP6A602_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)
5 / 12
ALA A 124
ILE A  23
LEU A 160
ILE A  18
TYR A   9
1.74A
None
APR  A 201 (-4.0A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_B_CP6B702_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)
5 / 12
ALA C 124
ILE C  23
LEU C 160
ILE C  18
TYR C   9
1.71A
None
APR  C 201 (-3.9A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_A_CP6A602_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)
5 / 12
ALA C 124
ILE C  23
LEU C 160
ILE C  18
TYR C   9
1.71A
None
APR  C 201 (-3.9A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_A_CP6A602_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)
5 / 12
ALA D 124
ILE D  23
LEU D 160
ILE D  18
TYR D   9
1.73A
None
APR  D 201 (-3.8A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_B_CP6B702_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)
5 / 12
ALA B 124
ILE B  23
LEU B 160
ILE B  18
TYR B   9
1.72A
None
APR  B 201 (-3.8A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_B_CP6B702_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)
5 / 12
ALA A 124
ILE A  23
LEU A 160
ILE A  18
TYR A   9
1.74A
None
APR  A 201 (-4.0A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_A_CP6A602_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)
5 / 12
ALA B 124
ILE B  23
LEU B 160
ILE B  18
TYR B   9
1.72A
None
APR  B 201 (-3.8A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UM5_B_CP6B709_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wq3 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
5 / 10
ILE A6951
PHE A6868
THR A6918
SER A7089
ILE A7088
1.57A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_A_CP6A602_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wq3 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
5 / 12
VAL A6807
ALA A6990
LEU A6825
ILE A7035
THR A6989
1.70A
None
None
GTA  A7102 (-3.8A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KM0_A_CP6A201_1
(DIHYDROFOLATE
REDUCTASE)
6wq3 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
5 / 10
ILE A6866
ALA A6905
ASP A6895
LEU A6848
THR A6908
1.75A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BL9_A_CP6A1240_1
(DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wq3 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
5 / 12
ILE A6925
ALA A6960
PHE A6954
ILE A7088
ILE A6866
1.42A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_B_CP6B702_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wq3 NSP10
(SARS-CoV-2)
5 / 12
VAL B4350
MET B4375
THR B4354
ILE B4352
THR B4309
1.41A
None
None
None
None
SO4  B4404 (-3.8A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QGT_A_CP6A609_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wq3 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
5 / 10
ALA A6990
PHE A7003
SER A7000
SER A6999
THR A6989
1.77A
None
None
GTA  A7102 (-2.6A)
GTA  A7102 (-2.5A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KM0_B_CP6B201_1
(DIHYDROFOLATE
REDUCTASE)
6wq3 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
5 / 12
ILE A6866
ALA A6905
ASP A6895
LEU A6848
THR A6908
1.73A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UM5_B_CP6B709_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wq3 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
5 / 10
ILE A6951
PHE A6868
THR A6918
SER A7089
THR A6949
1.77A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_B_CP6B702_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wq3 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
5 / 12
VAL A6807
ALA A6990
LEU A6825
ILE A7035
THR A6989
1.69A
None
None
GTA  A7102 (-3.8A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BLA_A_CP6A302_1
(DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wq3 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
5 / 11
ILE A6925
ALA A6960
PHE A6954
ILE A7088
ILE A6866
1.37A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QGT_B_CP6B609_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wq3 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
5 / 10
ILE A7079
ALA A7056
ILE A7065
ILE A7080
THR A7055
1.48A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1J3J_A_CP6A609_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wq3 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
5 / 10
ILE A6925
ALA A6960
PHE A6954
ILE A7088
ILE A6866
1.44A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UM5_A_CP6A609_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wq3 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
5 / 10
ILE A6951
PHE A6868
THR A6918
SER A7089
ILE A7088
1.60A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BLA_A_CP6A302_1
(DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wq3 2'-O-METHYLTRANSFERA
SE
NSP10
(SARS-CoV-2)
5 / 11
ALA A6881
ASP A6904
ASN B4293
ILE B4291
THR A6880
1.72A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QGT_A_CP6A609_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wq3 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
5 / 10
ILE A6925
ALA A6960
PHE A6954
ILE A7088
ILE A6866
1.42A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BL9_A_CP6A1240_1
(DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wq3 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
5 / 12
ILE A7005
ALA A6990
PHE A6991
SER A6999
THR A6989
1.79A
None
None
None
GTA  A7102 (-2.5A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QGT_B_CP6B609_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wq3 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
5 / 10
ILE A6925
ALA A6960
PHE A6954
ILE A7088
ILE A6866
1.32A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_A_CP6A602_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wq3 NSP10
(SARS-CoV-2)
5 / 12
VAL B4350
MET B4375
THR B4354
ILE B4352
THR B4309
1.42A
None
None
None
None
SO4  B4404 (-3.8A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QG2_B_CP6B709_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wrh PEPTIDASE C16
(SARS-CoV-2)
5 / 11
ILE A 123
PHE A 241
SER A 180
LEU A 125
THR A 259
1.71A19.80
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QG2_A_CP6A609_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6wrh PEPTIDASE C16
(SARS-CoV-2)
5 / 10
ILE A 151
ALA A  86
ASN A 156
SER A  78
THR A  90
1.77A19.80
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BL9_A_CP6A1240_1
(DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6yhu REPLICASE
POLYPROTEIN 1A
(SARS-CoV-2)
5 / 12
ALA C  48
LEU D 103
SER C  57
ILE D 120
THR C  45
1.78A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_A_CP6A602_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6yla SPIKE GLYCOPROTEIN
(SARS-CoV-2)
5 / 12
VAL A 511
ALA A 397
ILE A 358
PHE A 342
ILE A 434
1.57A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_A_CP6A602_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6yla SPIKE GLYCOPROTEIN
(SARS-CoV-2)
5 / 12
VAL E 511
ALA E 397
ILE E 358
PHE E 342
ILE E 434
1.59A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_B_CP6B702_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6yla SPIKE GLYCOPROTEIN
(SARS-CoV-2)
5 / 12
VAL E 511
ALA E 397
ILE E 358
PHE E 342
ILE E 434
1.60A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_B_CP6B702_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6yla SPIKE GLYCOPROTEIN
(SARS-CoV-2)
5 / 12
VAL A 511
ALA A 397
ILE A 358
PHE A 342
ILE A 434
1.58A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_A_CP6A602_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6yor SPIKE GLYCOPROTEIN
(SARS-CoV-2)
5 / 12
VAL E 511
ALA E 397
ILE E 358
PHE E 342
ILE E 434
1.58A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_B_CP6B702_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6yor SPIKE GLYCOPROTEIN
(SARS-CoV-2)
5 / 12
VAL E 511
ALA E 397
ILE E 358
PHE E 342
ILE E 434
1.59A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_B_CP6B702_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6yor SPIKE GLYCOPROTEIN
(SARS-CoV-2)
5 / 12
VAL A 511
ALA A 397
ILE A 358
PHE A 342
ILE A 434
1.60A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_A_CP6A602_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6yor SPIKE GLYCOPROTEIN
(SARS-CoV-2)
5 / 12
VAL A 511
ALA A 397
ILE A 358
PHE A 342
ILE A 434
1.58A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_A_CP6A602_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)
5 / 12
ALA A 124
ILE A  23
LEU A 160
ILE A  18
TYR A   9
1.72A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_A_CP6A602_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)
5 / 12
ALA D 124
ILE D  23
LEU D 160
ILE D  18
TYR D   9
1.73A
None
EDO  D 208 (-4.0A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_B_CP6B702_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)
5 / 12
ALA D 124
ILE D  23
LEU D 160
ILE D  18
TYR D   9
1.73A
None
EDO  D 208 (-4.0A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_B_CP6B702_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)
5 / 12
ALA C 124
ILE C  23
LEU C 160
ILE C  18
TYR C   9
1.73A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_A_CP6A602_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)
5 / 12
ALA E 124
ILE E  23
LEU E 160
ILE E  18
TYR E   9
1.73A
None
EDO  E 205 (-4.2A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_B_CP6B702_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)
5 / 12
ALA B 124
ILE B  23
LEU B 160
ILE B  18
TYR B   9
1.74A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_A_CP6A602_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)
5 / 12
ALA B 124
ILE B  23
LEU B 160
ILE B  18
TYR B   9
1.73A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_B_CP6B702_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)
5 / 12
ALA E 124
ILE E  23
LEU E 160
ILE E  18
TYR E   9
1.73A
None
EDO  E 205 (-4.2A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_B_CP6B702_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)
5 / 12
ALA A 124
ILE A  23
LEU A 160
ILE A  18
TYR A   9
1.73A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_A_CP6A602_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)
5 / 12
ALA C 124
ILE C  23
LEU C 160
ILE C  18
TYR C   9
1.72A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_A_CP6A602_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)
5 / 12
ALA D 124
ILE D  23
LEU D 160
ILE D  18
TYR D   9
1.76A
None
APR  D 201 (-3.9A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_B_CP6B702_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)
5 / 12
ALA B 124
ILE B  23
LEU B 160
ILE B  18
TYR B   9
1.78A
None
APR  B 201 (-4.1A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_A_CP6A602_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)
5 / 12
ALA E 124
ILE E  23
LEU E 160
ILE E  18
TYR E   9
1.73A
None
APR  E 201 (-4.1A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_B_CP6B702_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)
5 / 12
ALA A 124
ILE A  23
LEU A 160
ILE A  18
TYR A   9
1.75A
None
APR  A 201 (-3.9A)
None
None
EDO  A 202 (-4.6A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_B_CP6B702_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)
5 / 12
ALA D 124
ILE D  23
LEU D 160
ILE D  18
TYR D   9
1.77A
None
APR  D 201 (-3.9A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_A_CP6A602_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)
5 / 12
ALA A 124
ILE A  23
LEU A 160
ILE A  18
TYR A   9
1.75A
None
APR  A 201 (-3.9A)
None
None
EDO  A 202 (-4.6A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_A_CP6A602_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)
5 / 12
ALA C 124
ILE C  23
LEU C 160
ILE C  18
TYR C   9
1.75A
None
APR  C 201 (-3.9A)
None
None
EDO  C 204 ( 4.9A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_B_CP6B702_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)
5 / 12
ALA C 124
ILE C  23
LEU C 160
ILE C  18
TYR C   9
1.75A
None
APR  C 201 (-3.9A)
None
None
EDO  C 204 ( 4.9A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_A_CP6A602_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)
5 / 12
ALA B 124
ILE B  23
LEU B 160
ILE B  18
TYR B   9
1.78A
None
APR  B 201 (-4.1A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_B_CP6B702_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)
5 / 12
ALA E 124
ILE E  23
LEU E 160
ILE E  18
TYR E   9
1.74A
None
APR  E 201 (-4.1A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_A_CP6A602_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)
5 / 12
ALA A 124
ILE A  23
LEU A 160
ILE A  18
TYR A   9
1.71A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_B_CP6B702_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)
5 / 12
ALA C 124
ILE C  23
LEU C 160
ILE C  18
TYR C   9
1.71A
None
EDO  C 206 (-4.1A)
EDO  C 203 (-3.7A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_B_CP6B702_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)
5 / 12
ALA B 124
ILE B  23
LEU B 160
ILE B  18
TYR B   9
1.72A
None
EDO  B 202 (-4.0A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_B_CP6B702_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)
5 / 12
ALA A 124
ILE A  23
LEU A 160
ILE A  18
TYR A   9
1.71A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_A_CP6A602_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)
5 / 12
ALA B 124
ILE B  23
LEU B 160
ILE B  18
TYR B   9
1.72A
None
EDO  B 202 (-4.0A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_A_CP6A602_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)
5 / 12
ALA C 124
ILE C  23
LEU C 160
ILE C  18
TYR C   9
1.70A
None
EDO  C 206 (-4.1A)
EDO  C 203 (-3.7A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BL9_A_CP6A1240_1
(DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
7btf NSP12
NSP8
(SARS-CoV-2)
5 / 12
ILE A 539
ALA A 376
LEU B  91
PHE A 504
SER A 384
1.71A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KM0_B_CP6B201_1
(DIHYDROFOLATE
REDUCTASE)
7btf NSP12
(SARS-CoV-2)
5 / 12
ALA A 400
THR A 393
ILE A 450
TYR A 674
THR A 402
1.69A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_A_CP6A602_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
7btf NSP12
(SARS-CoV-2)
5 / 12
ALA A 400
THR A 393
ILE A 450
TYR A 674
THR A 402
1.73A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_A_CP6A602_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
7btf NSP7
NSP8
(SARS-CoV-2)
5 / 12
VAL D 115
ILE D 107
ASP C  67
LEU C  13
TYR D 149
1.45A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_A_CP6A602_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
7btf NSP12
(SARS-CoV-2)
5 / 12
VAL A 693
ILE A 589
PHE A 480
ILE A 696
THR A 686
1.61A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KM0_A_CP6A201_1
(DIHYDROFOLATE
REDUCTASE)
7btf NSP12
(SARS-CoV-2)
5 / 10
ALA A 400
THR A 393
ILE A 450
TYR A 674
THR A 402
1.73A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AOG_B_CP6B704_0
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
7btf NSP12
(SARS-CoV-2)
5 / 10
VAL A 475
ALA A 747
PHE A 745
VAL A 700
TYR A 479
1.57A20.82
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_B_CP6B702_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
7btf NSP12
(SARS-CoV-2)
5 / 12
ALA A 400
THR A 393
ILE A 450
TYR A 674
THR A 402
1.72A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KM0_B_CP6B201_1
(DIHYDROFOLATE
REDUCTASE)
7btf NSP12
(SARS-CoV-2)
5 / 12
ALA A 685
ASP A 684
GLN A 661
LEU A 527
THR A 686
1.75A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_B_CP6B702_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
7btf NSP7
NSP8
(SARS-CoV-2)
5 / 12
ALA D 110
ILE D 107
ASP C  67
LEU C  13
TYR D 149
1.57A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_A_CP6A602_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
7btf NSP12
(SARS-CoV-2)
5 / 12
VAL A 860
ILE A 837
LEU A 883
ILE A 888
TYR A 921
1.77A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_A_CP6A602_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
7btf NSP7
NSP8
(SARS-CoV-2)
5 / 12
ALA D 110
ILE D 107
ASP C  67
LEU C  13
TYR D 149
1.58A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_B_CP6B702_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
7btf NSP12
(SARS-CoV-2)
5 / 12
VAL A 693
ILE A 589
PHE A 480
ILE A 696
THR A 686
1.62A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KM0_B_CP6B201_1
(DIHYDROFOLATE
REDUCTASE)
7btf NSP12
(SARS-CoV-2)
5 / 12
ALA A 688
ILE A 589
THR A 586
ILE A 696
THR A 687
1.66A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_B_CP6B702_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
7btf NSP7
NSP8
(SARS-CoV-2)
5 / 12
VAL D 115
ILE D 107
ASP C  67
LEU C  13
TYR D 149
1.45A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BL9_A_CP6A1240_1
(DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
7btf NSP12
(SARS-CoV-2)
5 / 12
ALA A 376
LEU A 372
MET A 566
SER A 518
THR A 538
1.61A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BLA_A_CP6A302_1
(DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
7btf NSP12
(SARS-CoV-2)
5 / 11
ILE A 579
ALA A 585
PHE A 480
ASN A 695
THR A 582
1.69A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AOG_A_CP6A704_0
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
7btf NSP12
(SARS-CoV-2)
5 / 10
VAL A 475
ALA A 747
PHE A 745
VAL A 700
TYR A 479
1.57A20.82
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BL9_A_CP6A1240_1
(DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
7btf NSP12
(SARS-CoV-2)
5 / 12
ILE A 536
LEU A 366
SER A 363
ILE A 333
TYR A 530
1.57A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BL9_A_CP6A1240_1
(DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
7buy VIRUS MAIN PROTEASE
(SARS-CoV-2)
5 / 12
ASP A 295
PHE A 294
SER A 158
ILE A 152
THR A 292
1.68A
DMS  A 406 ( 4.7A)
None
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_A_CP6A602_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
7bv1 NSP12
(SARS-CoV-2)
5 / 12
VAL A 693
ILE A 589
PHE A 480
ILE A 696
THR A 686
1.60A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QGT_A_CP6A609_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
7bv1 NSP12
NSP8
(SARS-CoV-2)
5 / 10
ILE B 120
ALA B 125
SER A 397
SER A 672
THR B 124
1.77A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BL9_A_CP6A1240_1
(DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
7bv1 NSP7
NSP8
(SARS-CoV-2)
5 / 12
ILE D 132
LEU D 128
SER C  61
SER C  57
ILE D 106
1.49A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KM0_B_CP6B201_1
(DIHYDROFOLATE
REDUCTASE)
7bv1 NSP12
(SARS-CoV-2)
5 / 12
ALA A 688
ILE A 589
THR A 586
ILE A 696
THR A 687
1.60A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BL9_A_CP6A1240_1
(DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
7bv1 NSP7
NSP8
(SARS-CoV-2)
5 / 12
ALA D 188
LEU D 128
PHE D 147
SER C  57
ILE D 106
1.75A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AOG_B_CP6B704_0
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
7bv1 NSP12
(SARS-CoV-2)
5 / 10
VAL A 475
ALA A 747
PHE A 745
VAL A 700
TYR A 479
1.52A20.96
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QG2_B_CP6B709_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
7bv1 NSP12
(SARS-CoV-2)
5 / 11
MET A 380
ASN A 360
SER A 363
ILE A 333
TYR A 530
1.79A20.35
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_B_CP6B702_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
7bv1 NSP12
(SARS-CoV-2)
5 / 12
VAL A 476
ALA A 634
PHE A 480
SER A 759
ILE A 696
1.72A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_B_CP6B702_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
7bv1 NSP12
(SARS-CoV-2)
5 / 12
VAL A 693
ILE A 589
PHE A 480
ILE A 696
THR A 686
1.61A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KM0_B_CP6B201_1
(DIHYDROFOLATE
REDUCTASE)
7bv1 NSP8
(SARS-CoV-2)
5 / 12
ILE D 185
ALA D 188
ILE D 156
THR D 141
ILE D 132
1.67A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AOG_A_CP6A704_0
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
7bv1 NSP12
(SARS-CoV-2)
5 / 10
VAL A 475
ALA A 747
PHE A 745
VAL A 700
TYR A 479
1.52A20.96
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_A_CP6A602_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
7bv1 NSP12
(SARS-CoV-2)
5 / 12
VAL A 476
ALA A 634
PHE A 480
SER A 759
ILE A 696
1.71A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BL9_A_CP6A1240_1
(DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
7bv2 NSP12
(SARS-CoV-2)
5 / 12
ALA A 125
LEU A 240
ASP A 208
SER A 709
THR A 123
1.76A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KM0_A_CP6A201_1
(DIHYDROFOLATE
REDUCTASE)
7bv2 NSP12
(SARS-CoV-2)
5 / 10
PHE A  48
THR A 206
ILE A  37
TYR A 728
THR A 710
1.76A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_A_CP6A602_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
7bv2 NSP12
(SARS-CoV-2)
5 / 12
VAL A 476
ALA A 634
PHE A 480
SER A 759
ILE A 696
1.72A
None
None
None
U  P  20 ( 2.8A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KM0_B_CP6B201_1
(DIHYDROFOLATE
REDUCTASE)
7bv2 NSP12
(SARS-CoV-2)
5 / 12
ALA A 688
ILE A 589
THR A 586
ILE A 696
THR A 687
1.58A
F86  P 102 ( 4.1A)
None
None
None
F86  P 102 (-3.6A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_A_CP6A602_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
7bv2 NSP12
(SARS-CoV-2)
5 / 12
VAL A 693
ILE A 589
PHE A 480
ILE A 696
THR A 686
1.54A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QG2_B_CP6B709_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
7bv2 NSP12
(SARS-CoV-2)
5 / 11
ASP A 738
PHE A 741
ASN A 722
LEU A 723
THR A 739
1.79A20.35
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BL9_A_CP6A1240_1
(DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
7bv2 NSP12
(SARS-CoV-2)
5 / 12
ALA A 376
LEU A 372
MET A 566
SER A 518
THR A 538
1.56A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_B_CP6B702_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
7bv2 NSP12
(SARS-CoV-2)
5 / 12
VAL A 476
ALA A 634
PHE A 480
SER A 759
ILE A 696
1.73A
None
None
None
U  P  20 ( 2.8A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KM0_B_CP6B201_1
(DIHYDROFOLATE
REDUCTASE)
7bv2 NSP12
(SARS-CoV-2)
5 / 12
ALA A 685
ASP A 684
GLN A 661
LEU A 527
THR A 686
1.54A
A  T  11 ( 4.7A)
None
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_B_CP6B702_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
7bv2 NSP12
(SARS-CoV-2)
5 / 12
VAL A 299
ALA A 656
SER A 343
LEU A 329
TYR A 653
1.80A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BL9_A_CP6A1240_1
(DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
7bv2 NSP12
NSP8
(SARS-CoV-2)
5 / 12
ILE A 539
ALA A 376
LEU B  91
PHE A 504
SER A 384
1.73A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QFX_B_CP6B702_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
7bv2 NSP12
(SARS-CoV-2)
5 / 12
VAL A 693
ILE A 589
PHE A 480
ILE A 696
THR A 686
1.55A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AOG_B_CP6B704_0
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
7bv2 NSP12
(SARS-CoV-2)
5 / 10
VAL A 475
ALA A 747
PHE A 745
VAL A 700
TYR A 479
1.54A20.96
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AOG_A_CP6A704_0
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
7bv2 NSP12
(SARS-CoV-2)
5 / 10
VAL A 475
ALA A 747
PHE A 745
VAL A 700
TYR A 479
1.55A20.96
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KM0_B_CP6B201_1
(DIHYDROFOLATE
REDUCTASE)
7bv2 NSP12
(SARS-CoV-2)
5 / 12
PHE A  48
THR A 206
ILE A  37
TYR A 728
THR A 710
1.76A
None